These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34157386)

  • 1. Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Alhinai ZA; Elsidig N
    Int J Infect Dis; 2021 Sep; 110():258-260. PubMed ID: 34157386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waning antibody levels after COVID-19 vaccination with mRNA Comirnaty and inactivated CoronaVac vaccines in blood donors, Hong Kong, April 2020 to October 2021.
    Kwok SL; Cheng SM; Leung JN; Leung K; Lee CK; Peiris JM; Wu JT
    Euro Surveill; 2022 Jan; 27(2):. PubMed ID: 35027105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Incidence Proportion as a Function of Regional Testing Strategy, Vaccination Coverage, and Vaccine Type.
    Totolian AA; Smirnov VS; Krasnov AA; Ramsay ES; Dedkov VG; Popova AY
    Viruses; 2023 Oct; 15(11):. PubMed ID: 38005859
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
    Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccines.
    Ndwandwe D; Wiysonge CS
    Curr Opin Immunol; 2021 Aug; 71():111-116. PubMed ID: 34330017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could live attenuated vaccines better control COVID-19?
    Okamura S; Ebina H
    Vaccine; 2021 Sep; 39(39):5719-5726. PubMed ID: 34426024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.
    Li XN; Huang Y; Wang W; Jing QL; Zhang CH; Qin PZ; Guan WJ; Gan L; Li YL; Liu WH; Dong H; Miao YT; Fan SJ; Zhang ZB; Zhang DM; Zhong NS
    Emerg Microbes Infect; 2021 Dec; 10(1):1751-1759. PubMed ID: 34396940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals.
    Li J; Chen W; Chen M; Bai S; Yuan Q; Wu J
    Hum Vaccin Immunother; 2021 Oct; 17(10):3310-3313. PubMed ID: 34348570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A global epidemiological analysis of COVID-19 vaccine types and clinical outcomes.
    Alhinai Z; Park S; Choe YJ; Michelow IC
    Int J Infect Dis; 2022 Nov; 124():206-211. PubMed ID: 36155824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of good governance in the race for global vaccination during the COVID-19 pandemic.
    Tatar M; Faraji MR; Montazeri Shoorekchali J; Pagán JA; Wilson FA
    Sci Rep; 2021 Nov; 11(1):22440. PubMed ID: 34789826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-irradiated SARS-CoV-2 vaccine candidate, OZG-38.61.3, confers protection from SARS-CoV-2 challenge in human ACEII-transgenic mice.
    Turan RD; Tastan C; Dilek Kancagi D; Yurtsever B; Sir Karakus G; Ozer S; Abanuz S; Cakirsoy D; Tumentemur G; Demir S; Seyis U; Kuzay R; Elek M; Kocaoglu ME; Ertop G; Arbak S; Acikel Elmas M; Hemsinlioglu C; Hatirnaz Ng O; Akyoney S; Sahin I; Kayhan CK; Tokat F; Akpinar G; Kasap M; Kocagoz AS; Ozbek U; Telci D; Sahin F; Yalcin K; Ratip S; Ince U; Ovali E
    Sci Rep; 2021 Aug; 11(1):15799. PubMed ID: 34349145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine nationalism: a predicament in ending the COVID-19 pandemic.
    Lagman JDN
    J Public Health (Oxf); 2021 Jun; 43(2):e375-e376. PubMed ID: 33730161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies.
    Fu Y; Zhao J; Wei X; Han P; Yang L; Ren T; Zhan S; Li L
    Front Public Health; 2022; 10():917732. PubMed ID: 35928479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine.
    Zhang J; He Q; An C; Mao Q; Gao F; Bian L; Wu X; Wang Q; Liu P; Song L; Huo Y; Liu S; Yan X; Yang J; Cui B; Li C; Wang J; Liang Z; Xu M
    Emerg Microbes Infect; 2021 Dec; 10(1):1598-1608. PubMed ID: 34278956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute transverse myelitis after inactivated COVID-19 vaccine.
    Erdem NŞ; Demirci S; Özel T; Mamadova K; Karaali K; Çelik HT; Uslu FI; Özkaynak SS
    Ideggyogy Sz; 2021 Jul; 74(7-08):273-276. PubMed ID: 34370410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 Kounis Syndrome Induced by Inactivated SARS-COV-2 Vaccine.
    Özdemir İH; Özlek B; Özen MB; Gündüz R; Bayturan Ö
    J Emerg Med; 2021 Oct; 61(4):e71-e76. PubMed ID: 34148772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Inactivated Virus and Protein-Based COVID-19 Vaccines.
    Hotez PJ; Bottazzi ME
    Annu Rev Med; 2022 Jan; 73():55-64. PubMed ID: 34637324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.